AQUATES™ Expert Commentary on FEMP Water Reuse Guidance The FEMP guidance correctly highlights one of the key challenges associated with decentralized water reuse systems: conventional biological treatment technologies, including MBR and SBR systems, often require significant installation footprint and may be sensitive to intermittent hydraulic loading, extended idle periods, and substantial variations in wastewater composition. AQUATES™ provides an alternative engineering approach through the proprietary AQUA-OR™ treatment technology, owned and commercialized by AEROCRANE LLC (USA), the technology owner and commercialization entity for the AQUATES™ platform. The AQUATES™ platform has been developed for the treatment and conditioning of challenging industrial and municipal water streams. Key advantages include: • Compact Footprint The modular AQUATES™ architecture can significantly reduce installation footprint compared with many conventional biological treatment systems. Systems may be deployed in modular or containerized Plug-and-Play configurations where space is limited. • Operational Stability Under Variable Conditions Unlike treatment processes dependent on maintaining active biological populations, the AQUA-OR™ process does not rely on biological biomass and may be applied under variable flow conditions and fluctuating wastewater characteristics. • Water Reuse Readiness The process is designed to reduce organic contaminants (BOD/COD), suspended solids, and microbiological contamination to support a variety of non-potable water reuse applications, including cooling tower makeup water, industrial service water, equipment washdown, and toilet flushing. Actual treatment performance depends on site-specific water characteristics and is verified through project-specific testing and validation. Regulatory and Compliance Readiness The AQUATES™ platform is designed using commercially available industrial components commonly accepted within U.S. and European markets, including equipment carrying applicable certifications, listings, and markings required by individual project specifications. System fabrication may be performed through qualified manufacturing partners operating under recognized quality and welding standards, including ISO 3834 and applicable American Welding Society (AWS) requirements. AEROCRANE LLC (USA), as the owner of the AQUA-OR™ technology and the AQUATES™ platform intellectual property, maintains exclusive control over proprietary process know-how, core treatment technologies, software architecture, and future technology developments. This approach supports the integration of AQUATES™ solutions into industrial, municipal, commercial, and water reuse projects while maintaining compliance with applicable engineering, safety, and regulatory requirements. Disclaimer Performance results, treatment objectives, regulatory compliance, and water reuse suitability are subject to site-specific evaluation, pilot testing, and applicable regulatory approvals.
Published by Andrew Andrew
AQUATES™ Expert Commentary on FEMP Water Reuse Guidance The FEMP guidance correctly highlights one of the key challenges associated with decentralized water reuse systems: conventional biological treatment technologies, including MBR and SBR systems, often require significant installation footprint and may be sensitive to intermittent hydraulic loading, extended idle periods, and substantial variations in wastewater composition. AQUATES™ provides an alternative engineering approach through the proprietary AQUA-OR™ treatment technology, owned and commercialized by AEROCRANE LLC (USA), the technology owner and commercialization entity for the AQUATES™ platform. The AQUATES™ platform has been developed for the treatment and conditioning of challenging industrial and municipal water streams. Key advantages include: • Compact Footprint The modular AQUATES™ architecture can significantly reduce installation footprint compared with many conventional biological treatment systems. Systems may be deployed in modular or containerized Plug-and-Play configurations where space is limited. • Operational Stability Under Variable Conditions Unlike treatment processes dependent on maintaining active biological populations, the AQUA-OR™ process does not rely on biological biomass and may be applied under variable flow conditions and fluctuating wastewater characteristics. • Water Reuse Readiness The process is designed to reduce organic contaminants (BOD/COD), suspended solids, and microbiological contamination to support a variety of non-potable water reuse applications, including cooling tower makeup water, industrial service water, equipment washdown, and toilet flushing. Actual treatment performance depends on site-specific water characteristics and is verified through project-specific testing and validation. Regulatory and Compliance Readiness The AQUATES™ platform is designed using commercially available industrial components commonly accepted within U.S. and European markets, including equipment carrying applicable certifications, listings, and markings required by individual project specifications. System fabrication may be performed through qualified manufacturing partners operating under recognized quality and welding standards, including ISO 3834 and applicable American Welding Society (AWS) requirements. AEROCRANE LLC (USA), as the owner of the AQUA-OR™ technology and the AQUATES™ platform intellectual property, maintains exclusive control over proprietary process know-how, core treatment technologies, software architecture, and future technology developments. This approach supports the integration of AQUATES™ solutions into industrial, municipal, commercial, and water reuse projects while maintaining compliance with applicable engineering, safety, and regulatory requirements. Disclaimer Performance results, treatment objectives, regulatory compliance, and water reuse suitability are subject to site-specific evaluation, pilot testing, and applicable regulatory approvals.